NCT03748732

Extensive Circumferential Partial Thickness Sclerectomy in Nanophthalmic Eyes

Status unknown NA Last updated 21 November 2018

What this trial tests

NA trial testing sclerectomy in Nanophthalmos in 30 participants. Status unknown.

Timeline

1 January 2011

Primary endpoint
1 January 2020

1 January 2020

Quick facts

Lead sponsor	Rafic Hariri University Hospital
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	non randomized
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	30
Start date	1 January 2011
Primary completion	1 January 2020
Estimated completion	1 January 2020
Sites	1 location across Lebanon

Drugs / interventions tested

• sclerectomy

Conditions studied

• Nanophthalmos — all drugs for Nanophthalmos →

Sponsor

Rafic Hariri University Hospital

Who can join

Eligibility, any sex, with Nanophthalmos. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Purpose: To describe an extensive scleral excision technique to treat or prevent uveal effusion in nanophthalmic eyes.

Design: Prospective interventional case series.

Methods:

* Setting: Institutional.
* Patient Population: Consecutive patients with nanophthalmos were operated on by one surgeon.
* Intervention Procedure: A single, 90% thickness scleral window extending from immediately behind the extraocular muscle insertions to the vortex veins was performed for 3 and 1/4 quadrants as a circumferential strip.
* Main Outcome Measure: Resolution or prevention of uveal effusion.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

1. Extensive circumferential partial-thickness sclerectomy in eyes with extreme nanophthalmos and spontaneous uveal effusion.
   Mansour A, Stewart MW, Shields CL, Hamam R, et al · · 2019 · cited 16× · PMID 30877130 · DOI 10.1136/bjophthalmol-2018-313702